Home Vaccines Page 3

Keyword: Vaccines

34 results found

Canadian businesses are grappling with how they’ll handle the vaccination of staff, and for some that means allowing workers to get the shot on company time. At least 35 tech companies in the country, including SkipTheDishes, Borrowell and FreshBooks, signed a pledge Friday from the Council of Canadian Innovators vowing to let their staff slip […]

Scotiabank awarded for adapting benefits in face of coronavirus

While the rollout of vaccines has the world cautiously optimistic about an economic recovery, a Scotiabank survey shows the coronavirus pandemic has Canadians concerned about their retirement future. According to the survey, 72 per cent of Canadians said they’re worried they’re not saving enough for retirement, while one-third (32 per cent) said they won’t be […]

  • By: Staff
  • January 25, 2021 April 14, 2021
  • 10:37
Dollar General, other U.S. companies, paying employees to get coronavirus vaccinations

Employees of a U.S.-based chain of discount stores will get four hours of regular pay after they’ve received the coronavirus vaccination. Dollar General Corp. is giving frontline, hourly team members the one-time payment to compensate them for the time taken away from the store to get vaccinated. Meanwhile, salaried team members will get additional store labour hours to […]

  • By: Staff
  • January 15, 2021 April 14, 2021
  • 09:02

With coronavirus vaccines rolling out across Canada, employers must consider the privacy and human rights implications of requiring vaccinations for their teams, says Shaun Parker, an associate with the law firm Osler, Hoskin & Harcourt. “In a mandatory-vaccination program, if an employee will suffer adverse effects due to a protected ground, the employer may have […]

Institutional investors facing brighter 2021 but challenges remain

While institutional investors are facing an “unquestionably brighter” economic outlook in 2021, challenges such as fluctuations in the U.S. and Canadian dollars still lie ahead, says Karl Schamotta, chief market strategist at Cambridge Global Payments. In terms of the global growth landscape, he says crowded trades have been fuelled across several asset classes based on an […]

Institutional investors facing inflation risk, ESG opportunities in 2021

While institutional investors are facing headwinds from unexpected inflation and geopolitical realignment in 2021, the coming year will also see rebounds for corporate earnings and equities, according to two new research papers from Mercer. “Non-stop social and technological change has increased at a rate as exciting as it’s bewildering and COVID-19 has resulted in an […]

  • By: Staff
  • December 16, 2020 April 23, 2021
  • 15:00
Vaccines providing an injection of hope for institutional investors

While there’s still a period of uncertainty ahead, the deployment of coronavirus vaccines is already having a positive effect on markets, according to a webinar hosted by FTSE Russell on Wednesday. In November, the global and U.S. equities markets saw double-digit returns following vaccine announcements by pharmaceutical firms Pfizer Inc., Moderna Inc. and AstraZeneca, said […]

Vaccine news a shot in the arm for value investing

Now is the time for institutional investors to buy value, small cap and cyclical stocks and hold steady while the economy builds back, says Bill Callahan, an investment strategist at Schroders. Indeed, energy and financial sector stocks saw gains Monday as investors are rotating from growth and large cap stocks after Moderna Inc. released data […]

Without vaccine, business as unusual for employers likely to continue until early 2022

Canadian employers that were hoping to get back to business as usual this fall have had those hopes dashed as the second wave of the pandemic pummels hospitals, as well as bottom lines and return-to-office plans. Our country is nowhere near herd immunity, which means without a safe and effective vaccine we’re still nowhere near returning to how […]

Webinar: Current health-care policies impacting private drug coverage

On May 12, Benefits Canada hosted a webinar to discuss the pharmaceutical industry’s efforts during the coronavirus crisis, as well as some key policy issues for Canadian insurers and their potential impact from the private-payer perspective. Since the end of April, 139 coronavirus treatments have been under investigation and Health Canada has approved several clinical trials […]